本页面由Tiger Trade Technology Pte. Ltd.提供服务

Soleno Therapeutics

52.57
0.0000
盘后52.570.00000.00%18:58 EDT
成交量:415.46万
成交额:2.19亿
市值:27.14亿
市盈率:134.79
高:52.68
开:52.57
低:52.53
收:52.57
52周最高:90.32
52周最低:29.43
股本:5,162.44万
流通股本:4,487.09万
量比:0.92
换手率:9.26%
股息:- -
股息率:- -
每股收益(TTM):0.3900
每股收益(LYR):0.3900
净资产收益率:6.01%
总资产收益率:2.09%
市净率:6.03
市盈率(LYR):134.79

数据加载中...

2025/01/24

重要事件披露

Form 8-K - Current report
2024/12/17

重要事件披露

Form 8-K - Current report
2024/11/26

重要事件披露

Form 8-K - Current report
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/21

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]